Volume | 437,882 |
|
|||||
News | - | ||||||
Day High | 0.1464 | Low High |
|||||
Day Low | 0.1211 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
NLS Pharmaceutics Ltd | NLSP | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.123 | 0.1211 | 0.1464 | 0.1367 | 0.1324 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
669 | 437,882 | US$ 0.1356264 | US$ 59,388 | - | 0.113 - 1.53 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:54:31 | formt | 854 | US$ 0.1299 | USD |
NLS Pharmaceutics Ltd Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
US$ 4.21M | - | - | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
NLS Pharmaceutics News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NLSP Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.1325 | 0.1464 | 0.113 | 0.1303068 | 230,446 | -0.0026 | -1.96% |
1 Month | 0.189 | 0.1929 | 0.113 | 0.1455245 | 264,063 | -0.0591 | -31.27% |
3 Months | 0.50 | 0.52 | 0.113 | 0.1725251 | 616,264 | -0.3701 | -74.02% |
6 Months | 0.51 | 0.7423 | 0.113 | 0.3712135 | 570,618 | -0.3801 | -74.53% |
1 Year | 1.47 | 1.53 | 0.113 | 0.492072 | 347,778 | -1.34 | -91.16% |
3 Years | 3.51 | 3.89 | 0.113 | 1.35 | 593,208 | -3.38 | -96.30% |
5 Years | 2.9965 | 7.35 | 0.113 | 2.64 | 795,856 | -2.87 | -95.66% |
NLS Pharmaceutics Description
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. |